tm
Seeing Is Believing
tm
Seeing Is Believing
LYEL is currently covered by 3 analysts with an average price target of $4.34. This is a potential upside of $2.17 (100%) from yesterday's end of day stock price of $2.17.
Lyell Immunopharma's activity chart (see below) currently has 2 price targets and 10 ratings on display. The stock rating distribution of LYEL is 87.5% BUY and 12.5% HOLD.
Highest price target for LYEL is $6, Lowest price target is $6, average price target is $4.34.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 29-Feb-2024. First documented stock forecast 12-Jul-2021.
Currently out of the existing stock ratings of LYEL, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
6
$3.7 (160.87%)
8
1 months 30 days ago
0/5 (0%)
$3.08 (105.48%)
Hold
4
$1.7 (73.91%)
7
1 years 3 months 4 days ago
0/3 (0%)
$0.96 (31.58%)
Buy
7
$4.7 (204.35%)
30
1 years 5 months 17 days ago
0/2 (0%)
$2.47 (54.53%)
What is LYEL (Lyell Immunopharma) average time for price targets to be met?
Which analyst has the current highest performing score on LYEL (Lyell Immunopharma) with a proven track record?
Which analyst has the current lower performing score on LYEL (Lyell Immunopharma) with a proven track record?
Which analyst has the most public recommendations on LYEL (Lyell Immunopharma)?
Which analyst is the currently most bullish on LYEL (Lyell Immunopharma)?
Which analyst is the currently most reserved on LYEL (Lyell Immunopharma)?
